This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Think Research Valuation

Is THNK undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of THNK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate THNK's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate THNK's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for THNK?

Key metric: As THNK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for THNK. This is calculated by dividing THNK's market cap by their current revenue.
What is THNK's PS Ratio?
PS Ratio	0.3x
Sales	CA$85.10m
Market Cap	CA$24.56m

THNK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.8x
Enterprise Value/EBITDA	-15.7x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does THNK's PS Ratio compare to its peers?

The above table shows the PS ratio for THNK vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.5x
CDX.H Cloud DX	6.2x	n/a	CA$12.1m
AVCR Avricore Health	1.4x	n/a	CA$6.1m
CRBK Carebook Technologies	0.5x	n/a	CA$6.7m
XYBN Xybion Digital	2x	n/a	CA$47.2m
THNK Think Research	0.3x	6.5%	CA$24.6m

Price-To-Sales vs Peers: THNK is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2.6x).

Price to Sales Ratio vs Industry

How does THNK's PS Ratio compare vs other companies in the CA Healthcare Services Industry?

7 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	2.1x	9.7%
THNK Think Research	0.3x	6.5%	US$17.84m
CRBK Carebook Technologies	0.5x	n/a	US$4.74m
KOVO Kovo+ Holdings	0.4x	n/a	US$4.25m

7 Companies		Estimated Growth	Market Cap
Industry Avg.	2.1x	30.9%
THNK Think Research	0.3x	1.0%	US$17.84m

No more companies

Price-To-Sales vs Industry: THNK is good value based on its Price-To-Sales Ratio (0.3x) compared to the North American Healthcare Services industry average (2.4x).

Price to Sales Ratio vs Fair Ratio

What is THNK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

THNK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.3x
Fair PS Ratio	0.7x

Price-To-Sales vs Fair Ratio: THNK is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Evome Medical Technologies

CA$12.4m

Develops, manufactures, and distributes medical devices and products in the Americas and internationally.

EVMT

CA$0.14

12.5%

-35.7%

NeuPath Health

CA$9.6m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

-2.9%

10.0%

Hamilton Thorne

CA$344.7m

Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.

HTL

CA$2.25

0.9%

77.2%